Loading…
Venmax Drugs & Pharmaceuticals (BSE 531015)₹14.65+5.40%Pharmaceuticals
At the end of the Jun 2026 quarter, Venmax Drugs & Pharmaceuticals' shareholders were: promoters 10.49%, public 89.51%. Promoter holding is down 3.34 percentage points from 13.83% a quarter earlier. 0.00% of promoter shares were pledged. It had 6,867 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 23.16% | 23.16% | 23.16% | 23.16% | 23.16% | 23.16% | 23.16% | 23.16% | 23.16% | 15.17% | 13.83% | 10.49% |
| DIIs | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 76.69% | 76.69% | 76.69% | 76.69% | 76.69% | 76.69% | 76.69% | 76.84% | 76.84% | 84.83% | 86.17% | 89.51% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,252 | 6,254 | 6,253 | 6,254 | 6,293 | 6,659 | 6,758 | 6,731 | 6,766 | 6,817 | 6,804 | 6,867 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Pushpa Bhaju | Public | 12.97% | New |
| Jugal Kishore Bhagat | Public | 11.21% | New |
| Venkat Narender Nuka | Promoter | 7.98% | −2.55 |
| Manish Grover | Public | 4.71% | −1.50 |
| Percy Homi Italia | Public | 4.04% | −1.30 |
| Wca Services Private Limited | Public | 3.47% | −1.11 |
| Mega Flex Plastics Limited | Public | 2.60% | −0.84 |
| Dr Tadla Tirumal Rao | Public | 2.35% | −0.74 |
| Shammi Khanna | Public | 2.15% | −0.69 |
| Sampati Devi Jain | Public | 1.74% | −0.55 |
| White Saffron Grains Llp | Public | 1.72% | −0.55 |
| Dwarka Prasad Gattani | Public | 1.72% | −0.54 |
| J Muralidharan | Public | 1.72% | −0.54 |
| Vincent Alex D'Mello | Public | 1.29% | −0.41 |
| Channel Plastics Private Limited | Public | 1.24% | −0.40 |
| Sankalp Sunil Wakkar | Public | 1.07% | −0.34 |
| N Achuta Bai | Promoter | 0.89% | −0.29 |
| Banda Usha | Promoter | 0.11% | −0.03 |
| Banda Shamrao | Promoter | 0.05% | −0.02 |
| G Padmaja | Promoter | 0.04% | −0.02 |
| K Chakradhar | Promoter | 0.04% | −0.02 |
| Mohan Naidu Choppa | Promoter | 0.04% | −0.02 |
| N Jyothi Kiran | Promoter | 0.04% | −0.02 |
| D Amrutamma | Promoter | 0.02% | −0.01 |
| D Narayana Reddy | Promoter | 0.02% | −0.01 |
Promoters held 10.49% of Venmax Drugs & Pharmaceuticals at the end of the Jun 2026 quarter, down 12.67 percentage points from 23.16% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Venmax Drugs & Pharmaceuticals had 6,867 shareholders at the end of the Jun 2026 quarter, against 6,731 a year earlier.
Pushpa Bhaju (Public) held 12.97% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.